Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Nuclear Protein Kinase CLK1 Uses A Nontraditional Docking Mechanism To Select Physiological Substrates.
Bone And Soft Tissue Changes In Patients With Spinal Cord Injury And Multiple Sclerosis.
IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo.
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.
Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.
The effectiveness of the Permission, Limited Information, Specific suggestions, Intensive Therapy (PLISSIT) model based sexual counseling on the sexual function of women with Multiple Sclerosis who are sexually active.
Herpes Zoster Infection Involving Mandibular Division of Trigeminal Nerve and Ramsay Hunt Syndrome with Meningitis in an Immunocompetent Patient: A Rare Association.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis.
Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NO.
Overview of quantitative susceptibility mapping.
H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod.
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.
Consensus definitions for pediatric MS and other demyelinating disorders in childhood.
Major depressive disorder.
[Improving the sexual quality of life of people with multiple sclerosis].
Cre inducible site-specific recombination in zebrafish oligodendrocytes.
Administration of vitamin D3 induces CNPase and myelin oligodendrocyte glycoprotein expression in the cerebral cortex of the murine model of cuprizone-induced demyelination.
Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease.
Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.
Trifluoperazine: A Sprightly Old Drug.
Acute Disseminated Encephalomyelitis after Oral Therapy with Herbal Extracts: A Case Report.
Pages
« first
‹ previous
…
787
788
789
790
791
792
793
794
795
…
next ›
last »